Exact Sciences Corporation
EXAS
$103.75
-$0.19-0.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 878.38M | 850.74M | 811.09M | 706.79M | 713.42M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 878.38M | 850.74M | 811.09M | 706.79M | 713.42M |
| Cost of Revenue | 262.56M | 266.81M | 248.63M | 206.24M | 220.83M |
| Gross Profit | 615.83M | 583.93M | 562.45M | 500.55M | 492.59M |
| SG&A Expenses | 505.83M | 467.72M | 450.79M | 476.71M | 436.66M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 959.88M | 851.75M | 808.32M | 788.26M | 755.20M |
| Operating Income | -81.50M | -1.01M | 2.76M | -81.47M | -41.77M |
| Income Before Tax | -85.08M | -17.76M | -57.00K | -100.99M | -875.97M |
| Income Tax Expenses | 872.00K | 1.84M | 1.13M | 224.00K | -11.38M |
| Earnings from Continuing Operations | -85.96M | -19.59M | -1.19M | -101.22M | -864.59M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -85.96M | -19.59M | -1.19M | -101.22M | -864.59M |
| EBIT | -81.50M | -1.01M | 2.76M | -81.47M | -41.77M |
| EBITDA | -25.15M | 54.87M | 58.05M | -27.41M | 11.37M |
| EPS Basic | -0.45 | -0.10 | -0.01 | -0.54 | -4.67 |
| Normalized Basic EPS | -0.28 | 0.02 | 0.02 | -0.29 | -0.14 |
| EPS Diluted | -0.45 | -0.10 | -0.01 | -0.54 | -4.67 |
| Normalized Diluted EPS | -0.28 | 0.02 | 0.02 | -0.29 | -0.14 |
| Average Basic Shares Outstanding | 189.74M | 189.26M | 188.90M | 186.81M | 185.31M |
| Average Diluted Shares Outstanding | 189.74M | 189.26M | 188.90M | 186.81M | 185.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |